165 related articles for article (PubMed ID: 37240039)
1. Mucin-Phenotype and Expression of the Protein V-Set and Immunoglobulin Domain Containing 1 (VSIG1): New Insights into Gastric Carcinogenesis.
Satala CB; Jung I; Gurzu S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240039
[TBL] [Abstract][Full Text] [Related]
2. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
[TBL] [Abstract][Full Text] [Related]
3. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
7. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
8. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
11. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic classification of gastric signet ring cell carcinoma and its relationship with K-ras mutation.
Xiong ZF; Shi J; Fu ZH; Wan HP; Tu LX
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28453172
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
[TBL] [Abstract][Full Text] [Related]
14. V-set and immunoglobulin domain containing 1 (VSIG1) as an emerging target for epithelial-mesenchymal transition of gastric cancer.
Satala CB; Jung I; Kovacs Z; Stefan-Van Staden RI; Molnar C; Bara T; Patrichi AI; Gurzu S
Sci Rep; 2022 Sep; 12(1):16241. PubMed ID: 36171238
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
[TBL] [Abstract][Full Text] [Related]
16. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
Mizoshita T; Tsukamoto T; Inada KI; Hirano N; Tajika M; Nakamura T; Ban H; Tatematsu M
Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
Vernygorodskyi S
Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
[TBL] [Abstract][Full Text] [Related]
19. CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma.
Hong SM; Cho H; Moskaluk CA; Frierson HF; Yu E; Ro JY
Am J Clin Pathol; 2005 Sep; 124(3):361-70. PubMed ID: 16191504
[TBL] [Abstract][Full Text] [Related]
20. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
Domori K; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]